Rfp Financial Group LLC Gilead Sciences, Inc. Transaction History

Rfp Financial Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$63.15 - $72.88 $2,462 - $2,842	-39 Reduced 17.26%	187 $12,000
Q1 2024 May 09, 2024	SELL	$71.58 - $87.29 $4,080 - $4,975	-57 Reduced 20.14%	226 $16,000
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $4,835 - $5,483	66 Added 30.41%	283 $22,000
Q2 2023 Aug 01, 2023	BUY	$76.01 - $86.7 $380 - $433	5 Added 2.36%	217 $16,000
Q1 2023 Apr 26, 2023	SELL	$77.31 - $88.08 $386 - $440	-5 Reduced 2.3%	212 $17.6 Million
Q4 2022 Jan 24, 2023	BUY	$62.32 - $89.47 $13,523 - $19,414	217 New	217 $18.6 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Rfp Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Rfp Financial Group LLC with notifications on news.